Harrington, Kevin
Freeman, Daniel J.
Kelly, Beth
Harper, James
Soria, Jean-Charles
Article History
Accepted: 30 May 2019
First Online: 10 July 2019
Competing interests
: D.J.F., B.K., J.H. and J.-C.S. are employees of and own stocks and shares in AstraZeneca. K.H. has received research funding from Oncolytics Biotech and Genelux GmbH, and honoraria from Amgen, Viralytics and Oncos Therapeutics. J.-C.S. has received consultancy fees from AstraZeneca, Astex, Clovis, GSK, GamaMabs, Eli Lilly, MSD, Mission Therapeutics, Merus, Pfizer, PharmaMar Pierre Fabre, Roche-Genentech, Sanofi, Servier, Symphogen and Takeda, and has been a full-time employee of AstraZeneca since September 2017.